Psychiatry research has long experienced a stagnation stemming from a lack of understanding of the neurobiological underpinnings of phenomenologically defined mental disorders. Recently, the application of computational neuroscience to psychiatry research has shown great promise in establishing a link between phenomenological and pathophysiological aspects of mental disorders, thereby recasting current nosology in more biologically meaningful dimensions. In this review, we highlight recent investigations into computational neuroscience that have undertaken either theory-or data-driven approaches to quantitatively delineate the mechanisms of mental disorders. The theory-driven approach, including reinforcement learning models, plays an integrative role in this process by enabling correspondence between behavior and disorderspecific alterations at multiple levels of brain organization, ranging from molecules to cells to circuits. Previous studies have explicated a plethora of defining symptoms of mental disorders, including anhedonia, inattention, and poor executive function. The data-driven approach, on the other hand, is an emerging field in computational neuroscience seeking to identify disorder-specific features among high-dimensional big data. Remarkably, various machine-learning techniques have been applied to neuroimaging data, and the extracted disorderspecific features have been used for automatic casecontrol classification. For many disorders, the reported accuracies have reached 90% or more. However, we note that rigorous tests on independent cohorts are critically required to translate this research into clinical applications. Finally, we discuss the utility of the disorder-specific features found by the data-driven approach to psychiatric therapies, including neurofeedback. Such developments will allow simultaneous diagnosis and treatment of mental disorders using neuroimaging, thereby establishing 'theranostics' for the first time in clinical psychiatry.
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D ESPITE
LONG-STANDING AND everexpanding efforts in clinical and basic research, patients with mental disorders have not fully benefitted from their outcome. 1, 2 This unfortunate situation is reflected by the fact that mental disorders have ranked high in public health statistics, such as disability-adjusted life years (DALY) 3 and global economic burden of illness. 4 There are a lack of effective biomarkers that facilitate the early detection and unambiguous diagnosis of disorders, and an absence of effective pharmacological agents that lead to efficient recovery or prevent the relapse of disorders. A common criticism of psychiatric health care relates to the current symptom-based, operationalized definition of mental disorders, as standardized in the DSM 5 and ICD. 6 Here, each mental disorder is assumed to be distinct and defined by a constellation of non-specific symptoms or syndromes, with no concrete biological underpinnings. In practice, however, clinicians face many exceptions to this phenomenological stratification -similar symptoms are often present across multiple disorders, and patients commonly have psychiatric comorbidities. The reification of a given mental disorder is highly heterogeneous, 2, 7 suggesting that a single diagnosis may entail multiple pathogenic and pathophysiological mechanisms. Thus, biological research aiming to elucidate the etiology and pathophysiology of mental disorders has been obscured by the 'lens' of symptom-based stratification, 2 exemplified by the DSM and ICD, impeding substantial progress over the course of decades of psychiatry research.
To overcome this stagnation, growing attention has now been granted to a dimensional view aiming to recast mental disorders within a framework of biologically grounded, quantifiable constructs. 8 In this fiducial space, varying contributions of constructs (i.e., risk factors for disorders) constitute the spectrum of mental disorders within which current diagnoses, such as schizophrenia and mood disorder, are represented as entities with no definitive mutual boundaries. In this regard, the Research Domain Criteria (RDoC) project, 9 launched in 2009 by the US National Institute of Mental Health, has taken a leading role in identifying the constructs or 'biosignatures' 10 that encompass both normal and abnormal states of the brain circuitry. At present, the RDoC incorporates five domains of brain function (negative valence, positive valence, cognitive, social processes, and arousal/regulatory systems) to be characterized at multiple levels of brain organization, from genes, molecules, cells, and circuits to physiology in conjunction with an individual's behavior and self-report. On the other hand, apparently beyond the scope of the RDoC is how findings at each level can be aggregated to optimally elicit a comprehensive picture of the mechanisms of a mental disorder. 11 Thus, a complementary framework is required to disentangle the complex interactions among multiple levels and physical and social environments, 12 thereby achieving optimal integration of the multilevel findings.
In this review, we focus on the recent application of computational neuroscience in psychiatry research and discuss its potential role in: (i) revealing the biological underpinnings of mental disorders; (ii) deriving a novel framework for making objective, quantitative diagnoses; and (iii) developing treatment regimens in a clinical setting. The principal goal of computational neuroscience is to establish a mechanistic model of the brain that provides an integrative account for human behavior. Such a model can take either a theory-or data-driven approach. 12 Theorydriven approaches, including popular reinforcement learning (RL) 13 and game-theoretic models, 14 have been applied in psychiatry research 15, 16 and provide a quantitative description of the mechanisms underlying aberrations of emotion, decision-making, executive function, and other functions. Data-driven approaches, on the other hand, have emerged more recently in psychiatry research, invoking growing attention, especially in the context of potential clinical applications. 12, 17, 18 The methodological framework of data-driven approaches typically involves a machinelearning technique, which is by nature disease nonspecific and thus more amenable to general clinical usage. To elaborate on data-driven approaches, we highlight recent functional connectivity investigations, 17 demonstrating the increasing interest in characterizing mental disorders as disruptions of brain connections, and the recent availability of multicenter neuroimaging data that allow the application of various machine-learning techniques to extract disease-specific brain features for objective diagnosis and treatment.
THEORY-BASED APPROACH AS A PROBE INTO MECHANISMS UNDERLYING SYMPTOMS OF MENTAL DISORDERS
The goal of computational neuroscience is to establish an integrative, mechanistic model of our cognitive, emotional, and social processes. 19 Such a model would provide insights into the causal relationships between multiple levels of the brain's organization; for example, how the deficit or excess of a particular neurotransmitter drives to a particular behavior. The emerging field of computational psychiatry can be viewed as an extension of computational neuroscience in terms of how models derived from a healthy, typically developed population can be extrapolated, or must be modified, to explain aberrant behaviors observed among patients with mental disorders.
Connectionist models, or parallel distributed processing (PDP) models, are the most classical approach in computational modeling that aim to conceptualize human perceptual and cognitive functions via an artificial neural network (i.e., the weighted interconnection of simple neuron-like processing units). 20 The information within the network is represented either in a single unit or by a pattern of activation over multiple units. Inputs into the network are processed through the propagation of activations in the units, and in many connectionist network models, the whole system eventually settles in the local minima of its energy state (attractor states). 21 The connection weights then trace the history of activation, representing the long-term memory of learning through experience. 21 Since its inception in the mid-1980s, the PDP framework has been successfully applied for modeling the acquisition of regular and irregular English tenses, 22 speech production, 23 and other brain functions, such as cognitive control 24 and consciousness. 25 In psychiatry research, attempts have been made to interpret various symptoms of schizophrenia using the PDP framework. 26 Previous studies have found abnormally excessive pruning of cortical connections in schizophrenia, and the computational model of this phenomenon has identified the emergence of a network pathology called a 'parasitic focus,' wherein the portion of neural modules was locked into a certain cognitive output irrespective of the state of the rest of the system. 26, 27 This aberrant mechanism was thought to underlie symptoms of schizophrenia, such as thought insertion, thought broadcasting, and auditory/visual hallucinations. 26 Other characteristics associated with schizophrenia, such as impaired cognitive flexibility and control, were also considered in a connectionist model that explicitly incorporated the prefrontal cortex as a distinct module, which was demonstrated to be impaired. 28 Decision-making has been a primary subject of investigation in computational psychiatry because aberrant decision-making constitutes the defining symptoms of many psychiatric conditions. 19 In this regard, RL models provide a powerful framework that relates the values of decision-making options to preceding actions and environments. More specifically, RL is concerned with the role of dopamine and its neural circuits in the basal ganglia and how reward-seeking and punishment-avoiding behaviors are affected by the presence (e.g., amount and timing) of reinforcers (reward and punishment). Such behaviors are directly connected to one's survival and constitute the principal concern of neural circuits. 15 A detailed description of RL, including model-based and model-free RL, is beyond the scope of this review. Instead, here we note that previous studies have associated aspects of RL with a wide variety of symptoms of mental disorders, including: (i) positive symptoms (e.g., delusions and hallucinations) in schizophrenia with abnormal reward prediction error, 29, 30 aberrant activity in response to neural stimuli in the limbic motivational systems, 31 and abnormal levels of incentive salience 32 due to abnormally elevated levels of dopaminergic neurotransmission; 33 (ii) negative symptoms in schizophrenia with failure to represent the expected value of rewards [34] [35] [36] and abnormal effect-cost computations; 37 (iii) anhedonia in depression with a loss of reward sensitivity in a manner distinct from that involving dopaminergic transmission; 38 and (iv) impulsivity in attentiondeficit hyperactivity disorder (ADHD) with impaired delay aversion caused by excessive discounting of delayed rewards. 39, 40 For more detail, see other dedicated reviews. 41, 42 Social behavior is another important subject of investigation in computational psychiatry. Inferring the intentions and affective states of others is crucial for appropriate behavior and survival in social environments. Impairments in social functioning severe enough to impact quality of life are observed in many mental disorders, including schizophrenia, autism spectrum disorder (ASD), and personality disorders. 43 Game-theoretic approaches have been extensively used to investigate interpersonal decision-making that involves social fairness, strategic cooperation, and competition. 44 For example, in a stag-hunt game, two players (a human and a computerized agent) are required to cooperate to hunt for a high-payoff mobile stag (a male deer) instead of a low-payoff stationary rabbit. 45 A model-based behavioral analysis allows for an estimation of the recursion depth of inference about the co-player's intention. A previous study revealed that individuals with ASD with more severe symptoms were less likely to exhibit a recursive inference. 46 Other gametheoretic investigations use a multiround trust game to probe normal and aberrant behaviors in reciprocal interactions. In this game, two players are endowed with a certain amount of money and play multiple rounds of monetary exchange according to the following rule: one player (an investor) entrusts some fraction of money in hand to the other player (a trustee) who actually receives triple the amount. The trustee then decides what fraction of the received money to transfer back to the investor. For optimal results, both players are required to cooperate by mentalizing the impact of one's actions on the other. Disorder-specific play styles have been observed in many mental disorders, including schizophrenia and other psychotic disorders, 47 major depressive disorder (MDD) and bipolar disorder, 48 ASD, 49 ADHD, 50 and borderline personality disorder. 51 Intriguingly, a Bayesian clustering approach yielded a pattern of clusters of healthy investors which, when investors were playing with trustees with mental disorders, significantly overlapped with the pattern correlating with the pathology of the trustees (i.e., ASD, ADHD, MDD, and borderline personality disorder). 52 These and other games derived from behavioral economics have been extensively employed in psychiatry research, providing a unique opportunity to phenotype individuals according to their behavior in social decision-making.
Lastly, we note that functional neuroimaging has been pivotal in deepening our understanding of the neural substrates of the modeled and phenotyped behaviors described in this section. Continuing efforts across multiple techniques will enable the multilevel integration of disorder-specific findings, contributing critically to establishing the objective and quantitative nosology of mental disorders in the future.
DATA-DRIVEN APPROACH FOR MAKING PREDICTIONS IN CLINICAL SETTINGS
For nearly two decades, neuroimaging has been an exploratory tool to identify structural, functional, and metabolic manifestations of mental disorders. Neuroimaging identifies features that may have a pivotal role in establishing a disorder's endophenotype, bridging its symptomatology and pathophysiology. A multitude of disorder-specific characteristics of the brain have been documented at the group level (i.e., case vs control), such as: regional gray matter volume [53] [54] [55] [56] and cortical thickness [57] [58] [59] [60] [61] measured in high-resolution structural magnetic resonance (MR) images; white matter organization measured by diffusion tensor imaging; 62-66 key metabolites measured in MR spectroscopy; [67] [68] [69] positron emission tomography; [70] [71] [72] [73] [74] patterns of activation associated with psychological tasks and functional connectivity in participants at rest during functional magnetic resonance imaging (fMRI), 17, 18 near-infrared spectroscopy, 75 and electroencephalogram. 76 While these disorder-specific alterations certainly contribute to the quantitative delineation of mental disorders, such findings have not led to the development of clinical methods to help determine the diagnostic and prognostic status of an individual. One major reason for this lack of development is that the effect size of the reported case-control separations is insufficient to permit classification on an individual basis. 18 Thus, a more sophisticated methodological framework is needed instead of the current simple thresholding to the observed casecontrol relationships. 18 In the past several years, a surge of data-driven computational neuroscience studies has applied machine-learning techniques to neuroimaging data to uncover disorder-specific structural and functional features of the brain. Such hypothesis-free studies led to the formation of classifiers that objectively and automatically assign a diagnostic label (case or control) to an individual. To date, a variety of classification schemes have been proposed, and the accuracy of classification has reached as high as 90% for many disorders, including schizophrenia, MDD, and ASD; see a recent comprehensive survey of previous machine-learning studies that reported the construction of neuroimaging-based classifiers. 18, 77, 78 To lay people, it may appear as though the advent of artificial intelligence in the psychiatric clinic has arrived and will soon be responsible for diagnostic and therapeutic decision-making. In the present review, such naïve optimism is discouraged, and it is instead argued that several critical technical hurdles must be cleared before machine-learning-based classification can complement current psychiatric medicine.
Case-control classification based on the resting-state functional connectivity of the brain
In the following paragraphs, we focus on previous studies that have applied machine-learning © 2016 The Authors Psychiatry and Clinical Neurosciences © 2016 Japanese Society of Psychiatry and Neurology techniques to resting-state functional-connectivity magnetic resonance imaging (rs-fcMRI) data. The investigations are based on measuring spontaneous brain activity while subjects are at rest in an MR scanner without behavioral manipulations. Functional connectivity describes the similarity of low-frequency (<0.08-0.1 Hz) blood-oxygenation level dependent (BOLD) signals between voxels or groups of voxels (e.g., anatomical regions), typically measured by Pearson correlations. More recently, connectivity within and between functional networks, such as default mode and sensorimotor networks, has also become a target of investigation. 79, 80 Functional connectivity can be measured either statically using the whole time series or dynamically within a predefined narrow time-window sliding across the time series. The pattern of low-frequency temporal correlations has been thought to reflect a personal history of Hebbian co-activation, as evidenced by previous reports on practice-induced changes in functional connectivity. 81 Currently, rs-fcMRI is an important tool for investigating the (dis)integrity of healthy and pathological brains of young and adult individuals, 17, 82 as well as of model animals in preclinical studies. Thus, rs-fcMRI is a potential means of facilitating translational psychiatry research.
Various machine-learning techniques have been applied to mass rs-fcMRI data to objectively identify disorder-specific abnormalities in mental disorders, with which automatic case-control classifications were employed. Table 1 summarizes the previous attempts for schizophrenia, 80, [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] MDD, [99] [100] [101] [102] ADHD, [103] [104] [105] [106] and ASD. [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] The take-home messages of this summary are as follows: (i) irrespective of disorder type, classification accuracy is, overall, 80-90%, comparable to those based on structural MRI data; 18, 78 (ii) in many studies, especially for schizophrenia and MDD, the sample per group (case or control) is typically comprised of fewer than 100 participants; (iii) for all schizophrenia and MDD studies, the imaging data were acquired at a single site, whereas for many ADHD and ASD studies, the imaging data came from multiple sites, thanks to the recent multicenter imaging campaigns for these disorders; 115, 116 (iv) inter-regional functional connectivity and the associated graph metrics are popular features used for classification; (v) head motions during scanning have been known to introduce artifacts in the functional connectivity estimate, 118, 119 the effects of which are controlled by regression, masking (scrubbing), 118 or independent component analysis; 120 (vi) BOLD signal fluctuations of non-neuronal origins, such as respiration and cardiac activity, are removed by regressing out the signals in white matter and cerebrospinal fluid, although further inclusion of global signal fluctuation into the regressor is not unanimous among the studies due to the recent controversy; 121, 122 (vii) support vector machine (SVM) and its variants are popular prediction methods, although some studies use classifiers with embedded regularization frameworks, such as least absolute shrinkage and selection operator (LASSO); (viii) -leave-one-out and k-fold cross-validation procedures are popular methods for model evaluation; and (ix) for all but one study, 114 the generalization capability of a classification scheme is untested in an independent cohort. We will elaborate more on this issue below.
Generalization of classification scheme
Among the properties above, a crucial factor that has hampered the clinical application of the machine-learning classification scheme is the lack of studies on their generalizability (i.e., whether or not a classification is effective in an independent population). The development of a classifier, including both the determination of a model form and the estimation of the associated parameters, proceeds with 'training' data, whereas the generalizability of a classifier must be evaluated using independent 'test' data. A rigorous assessment of a classifier's reliability on independent test data is particularly essential while determining clinical applicability. This stipulation is a harsh requirement for most previous neuroimaging studies because such studies typically rely on a small sample of participants that are recruited and scanned at a single imaging site. Although more recent multicenter neuroimaging projects have been ambitious in their target sample size, involving a few thousand or more participants, the issue of generalizability remains to be addressed.
Broadly speaking, generalization can be considered as two technical issues, namely overfitting and the treatment of nuisance variables (NV, to be described in the next section). Overfitting is a condition where a developed model perfectly describes the entire aspect of the training data, including the underlying relationship and associated noise, thereby making the fitting error asymptotically zero. 123, 124 The noise characteristics are most likely not replicated beyond the training data, therefore overfitting will not allow for accurate predictions of independent data. Overfitting occurs when the complexity of the model, for example, the number of explanatory variables (p), exceeds the sample size (n) (Fig. 1a) . Excessive model complexity results in an unintended fit into the noise structure of the data, as is often the case with neuroimaging studies because the dimension of model parameters tends to exceed the number of participants by a large factor (p ) n). For example, the number of voxels is typically~10 5 for functional and diffusion tensor images and~10 6 for structural MR images, whereas the number of participants incorporated into a single study is typically on the order of 10 2 to 10 3 . Balancing the complexity of a model against the available sample size of a training dataset (i.e., increasing n and reducing p) is therefore essential to improving prediction accuracy for independent data (Fig. 1b) .
Increasing the sample size to the order of~10 3 is not unrealistic if the design of a study allows for the incorporation of data from previous and ongoing large-scale imaging campaigns (e.g., imaging campaigns for ADHD, 116 ASD, 115 and the general population 125 ). Anonymized imaging and demographic data from these and other imaging projects are available at open-data repositories. 126, 127 Another more effective approach to mitigate the overfitting problem is to reduce the model's dimension, which is achieved via an unsupervised method for dimensionality reduction and/or a supervised method for feature reduction. 128 Using this approach is particularly important when the classification is based on functional connectivity, where the parameter dimension can be as large as the number of imaging elements squared. An unsupervised method for dimensionality reduction is typically employed during image data preprocessing. One simple and popular method is to segment the brain into subregions (typically~10 2 regions) using anatomical atlases, and then extract a representative measurement from each segmented region. Performing principal component 129 and independent component analyses 120 on fMRI time-series data and computing the mutual correlation of the extracted components is another popular unsupervised method. A supervised method of dimensionality reduction is achieved through a regularization procedure that is built into machinelearning algorithms, such as LASSO and Elastic Net techniques. In these cases, a loss function that is used to optimize the model incorporates a penalty term that controls the complexity of the model. In LASSO and Elastic Net, the penalty term includes a hyperparameter that specifies the sparsity of model coefficients (sparsity meaning fewer non-zero ing data (discovery cohort), the model fits to not only the true underlying relationship but also the noise structure inherent in the data. In this case, the ability of the model to predict external unseen data (validation cohort) becomes extremely poor. (b) An appropriate procedure to circumvent overfitting is to balance model complexity and the sample size of the training data. In addition to simply increasing the sample size, this may be achieved by supervised (such as least absolute shrinkage and selection operator [LASSO] and Elastic Net) and unsupervised (e.g., principal component and independent component analyses) techniques for dimensionality reduction and feature selection.
coefficients and therefore fewer parameters in the model) that is determined by a cross-validation procedure. 128 Some previous studies have used the regularization technique to reduce the number of features. 94, 98, 114 Proper handling of NV A particular pattern of interaction between disorderspecific and non-specific features (i.e., NV) can be exploited to inflate the classification performance. A simple but illustrative example is where data from one site contains younger patients and data from another site contains older control patients. In this case, age can be used to predict this particular dataset, but not the general population. Disease-nonspecific features include both the demographic factors of participants, such as age, 130 sex, 131 and medication profiles, 132 as well as conditions related to data acquisition, such as scanner specifications, 133 imaging parameters, 134 and instructions to participants. 135 Previous studies have indicated that all of these features affect MR data interpretation. Again, the pattern of interaction is often unique to the training data so that the classification scheme exploiting this interaction structure is doomed to yield catastrophic predictions for independent data.
Construction of a generalizable classifier
To avoid overfitting and unintended exploitation of disease-non-specific characteristics in the training data, it is essential that imaging studies proceed with a large sample of data across multiple imaging sites 136, 137 and with appropriate algorithms that both balance the complexity of the model and sample size and handle the effects of NV in selecting diseasespecific features from the neuroimaging data. In Table 1 , there are only three studies 104, 105, 114 wherein development of the classifier involved both training dataset (discovery cohort) and test dataset (validation cohort) from multiple imaging sites. However, in two 104, 105 of these studies, the training and test datasets were not completely independent because they were derived from the almost identical set of imaging sites. In one study, 104 classification performance for the test dataset was not better than that of a classifier based only on disease-non-specific, phenotypic information. In the other study, 105 classification performance was characterized by unbalanced sensitivity (59% at most) and specificity (up to 90-100%) in both the training and test datasets. The generalization of performance to independent validation cohorts was untested in these studies. In contrast, the remaining study 114 formed a classifier based on the dataset acquired at three sites. The construction of the classifier involved an L 1 -norm regularized sparse canonical correlation analysis (L 1 -SCCA) 138 and sparse logistic regression (SLR) 139 for concurrent removal of NV effects and dimensionality reduction (Fig. 2) . To date, this is the only study in which high classification performance was generalized to an independent cohort. Again, this underscores the importance of appropriate handling of overfitting and NV. For reference, if one extends the scope of the survey to include previous structural MRI studies, two studies 140, 141 have reported the construction of classifiers for patients with schizophrenia and normal controls and replicated classification performance in independent samples.
Utility of neuroimaging-based classifiers in psychiatry
What is the utility of generalization-proof neuroimaging-based classifiers in psychiatry? Can such a system be used in an outpatient psychiatry clinic as a screening tool to identify those in need of further medical assessment, or can it be used to provide complementary information for those patients whose diagnoses are hard to determine using the standard diagnostic procedure? Realistically, the utility of such a system as a screening tool must be considered at the intersection of the prevalence rate of a disorder, classification sensitivity and specificity, and scanning cost. For example, screening individuals for a disorder with a 1% prevalence rate (e.g., ASD) using a classifier with a sensitivity and specificity of 80% detects one true-positive case for approximately 25 false-positive cases. Whether or not this is acceptable from the viewpoint of medical economy actually depends on the efficiency and reliability of other existing screening tools. In this sense, a classifier may better be used in such a selected case where existing diagnostic procedures do not yield a definitive diagnosis and complementary information is needed to narrow down the possibilities.
Yet another raison d'être of a classifier is to aid in the recasting of mental disorders into a biologyoriented stratification instead of a symptom-based stratification (Fig. 3) . A classifier quantitatively delineates one's internal state as a likelihood of a specific disorder. A set of classifiers, each constructed for a certain type of disorder, will then provide a set of axes in a multi-dimensional space of mental disorders, where each individual is represented as a point, and a group of individuals with one type of disorder is represented as a cloud of points. Investigating the spatial distribution of clouds of patients with specific disorders will enable the quantitative characterization of mutual relationships for disorders, providing important clues for revising the definitions of disorders toward a biological viewpoint.
For example, determining new axes by maximizing variance will generate new categorizations of disorders.
A recent investigation 114 used a classifier for ASD to investigate its relation with other disorders, such as schizophrenia, MDD, and ADHD. The pattern of functional connectivity that is selected in a classifier, namely, the weighted linear summation (WLS) of the correlation indices of connections, represents the 'ASD-ness' of each individual. This biological measure was calculated for a group of patients with The results of this study revealed that only in the case of schizophrenia did the ASD-ness distribution of patients and controls differ significantly, suggesting that ASD and schizophrenia share some intrinsic functional connections. Interestingly, this finding was consistent with previous behavioral 142, 143 and genetic studies 144, 145 (Fig. 2) .
Prediction of treatment response and prognosis
Predicting clinical sequelae in a patient is another important area in psychiatry research to which machine-learning techniques may be applied. The features revealed as important for prediction may play a pivotal role in establishing the long-awaited
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Recasting current nosology in more biologically meaningful dimensions
Each axis represents proneness to a specific disorder derived from the corresponding FC-based classifier. trating the redefinition of mental disorders using functional connectivity (FC)-based classifiers. An FCbased classifier represents one's own proneness to a specific disorder. A set of classifiers, each constructed for a certain type of disorder, will then form a multidimensional fiducial space of mental disorders, in which mutual relations between the disorders can be quantitatively examined. ASD, autism spectrum disorder; MDD, major depressive disorder; OCD, obsessive-compulsive disorder; SCZ, schizophrenia.
Figure 2.
An example of development of a generalizable classifier for autism spectrum disorder (ASD). 114 (a) Yahata et al. 114 recently developed a generalizable classifier for ASD by applying a novel machine learning technique to a set of multi-site, resting-state functional connectivity magnetic resonance imaging (rs-fcMRI) data acquired from 74 adults with ASD and 107 demographically matched, typically developed (TD) individuals. For each individual, a pairwise interregional correlation matrix was formed for 140 regions of interest (ROI) using the mean regional time course of blood oxygenation level-dependent (BOLD) signals calculated from the preprocessed images. The set of correlation matrices, as well as associated demographic information (diagnostic label, age, sex, site scanned, medication status, etc.), was submitted to a cascade of two machine-learning techniques: L 1 -norm regularized sparse canonical correlation analysis (L 1 -SCCA) 138 and sparse logistic regression (SLR). 139 Briefly, the L 1 -SCCA procedure selects those functional connections (FCs) that are correlated with the individuals' diagnostic labels (ASD or TD) while discarding the FC under the influence of NV. Then, the remaining FCs (~10% of the total FCs considered initially) were further submitted to the SLR procedure, and those FCs most relevant to the diagnostic label were selected. (b) The result of these statistical procedures is a set of weights for the 16 finally selected FCs (0.2% of the total FCs). The weighted linear summation (WLS) of the corresponding correlation indices plus constant is the argument for the logistic function that maps the individual's WLS to the prediction of a diagnosis. The classification accuracy for the Japanese training data was 85%, with an area under the curve (AUC) of 0.93, indicating highly reliable classification. This classifier was further applied to an independent dataset adopted from the US ABIDE project. We confirmed that the reliability of the classifier was generalized to this independent cohort with a diverse ethnic background, in that the classification accuracy was 75% (AUC = 0.76), and the probability of achieving this accuracy was as small as P = 1.4 × 10
goal of 'precision medicine' in psychiatry 146 : providing a quantitative means to optimize therapeutic strategies on an individual basis. Individually optimized treatment may lead to reductions in the period of patient disability, and a decrease in adverse outcomes; both of these results present a significant benefit to public health. Table 2 lists a selection of previous work that has employed machine-learning classification to predict both treatment response [147] [148] [149] [150] [151] [152] [153] [154] [155] and prognosis [156] [157] [158] [159] [160] in psychiatric patients. For treatment response, the target of prediction includes both pharmacological (including antipsychotics for schizophrenia, 148 ω-3 fatty acids for ultra-high risk for psychosis, 150 antidepressants for MDD 155 and obsessive-compulsive disorder, 154 and methylphenidate for ADHD 151 ) and psychological intervention (cognitive behavioral therapy for alcohol-dependent individuals 147 and individuals with social anxiety disorder 152 ). For prognosis, the target of prediction includes state transition from at-risk mental state to psychosis, 156 chronic course of MDD, 159 resilience to or development of post-traumatic stress disorder symptoms, 157, 158 and relapses in alcohol dependence. 160 Classifier development typically proceeds with one or a few predefined sets of demographic, clinical, and biological parameters of individuals. As with the prediction of diagnosis, a support vector machine is the most popular classification algorithm. The accuracy of the predictions is generally greater than 70% or 0.7 represented as the area under the curve (AUC). However, generalizations of this performance in an independent cohort remained untested as yet. Except for a few studies, the sample size tends to be small to modest (n < 100). The use of neuroimaging, often combined with demographic and clinical measures, has been increasing recently, which should provide important information for understanding the neural correlates of treatment response and state transition. Because the prediction of prognosis entails temporal changes within an individual, future work may need to address the pattern of interaction between the features used in the classification and the environmental factors affecting an individual in order to improve prediction accuracy.
THERAPEUTIC APPLICATION
Neurofeedback, a descendant of the more general biofeedback, is a non-invasive method for modulating the activity of the whole brain or specific regions by providing an individual with feedback related to their current brain state. Upon presentation of this feedback, a person may attempt to self-regulate (increase or decrease) their activation levels towards a state appropriate for bringing about a desired behavior. 162 The successful modulation of activity is the result of operant conditioning, which can be therapeutic if employed in a clinical setting. The first wave of feedback studies came in the second half of the last century, when biofeedback with electroencephalography (EEG) was applied to a wide range of mental disorders, including ADHD, mood disorders, anxiety disorders, obsessivecompulsive disorder, alcoholism, and numerous others. However, no robust evidence yet exists to strongly support the clinical efficacy of EEG-based biofeedback. 162, 163 The second wave of feedback studies arrived at the turn of this century, when real-time fMRI was introduced as a new tool for neurofeedback (hereafter 'rtfMRI-nf'). Thanks to its high spatial resolution (~2-3 mm) and to the high computing power that supports online image reconstruction (with a delay of less than 1-2 s), rtfMRI-nf allows focal modulation of the brain with a latency of only 2-3 s. The regions of the brain that have been targets of modulation in previous studies include the insula, 164, 165 amygdala, 166, 167 prefrontal cortex, 168 and anterior cingulate cortex, 165 among others. In some studies, participants were reported to be able to modulate the activity of the target region; however, the lack of appropriate control conditions generally precluded a definitive interpretation that neurofeedback was indeed the primary factor that accounted for the observed modulation. 162, 163 More recently, interregional functional connectivity has become a target for neurofeedback studies. In one study, healthy individuals underwent 4 days of rtfMRI-nf sessions to train them to modulate the functional connection between two designated regions. Participants successfully changed their resting-state functional connectivity between the two regions and this alteration remained for more than 2 months, an encouraging result in terms of the therapeutic application of rtfMRI-nf. 169 For example, the set of functional connections shown in Figure 2 may be used as a possible therapeutic target for individuals with ASD during the rtfMRI-nf session. The WLS of the ASD classifier could be estimated for the participant in the scanner during an rtfMRI-nf ADHD, attention-deficit hyperactivity disorder; ADTree, alternating decision tree; aSN, anterior salience network; BN, Bayesian network; BOLD, blood oxygenation level-dependent; CBT, cognitive behavioral therapy; CV, cross validation; DA, discriminant analysis; dDMN, dorsal default mode network; DT, decision tree; DTI, diffusion tensor imaging; GPC, Gaussian process classification; HC, healthy control; LOOCV, leave-one-out cross validation; LR, logistic regression; LRR, logistic ridge regression; MDD, major depressive disorder; MRI, magnetic resonance imaging; NB, Naïve Bayes; OCD, obsessive compulsive disorder; PTSD, post-traumatic stress disorder; QIDS, Quick Inventory of Depressive Symptoms; RAVENS, regional analysis of volumes in normalized space; RF, random forest; ROI, region of interest; rsfMRI, resting-state functional magnetic resonance imaging; RSLVQ, robust soft learning vector quantization; STAR*D, sequenced treatment alternatives to relieve depression 161 ; SVM, support vector machine; TP, transition to psychosis; UHR, ultra high-risk.
© 2016 The Authors Psychiatry and Clinical Neurosciences © 2016 Japanese Society of Psychiatry and Neurology session. Thereafter, a sign-inverted WLS value could be presented to the individual with ASD as a neurofeedback target for increasing in an RL paradigm. Increases in the neurofeedback score lead to reductions in the WLS value. Successful completion of the rtfMRI-nf sessions might then bring about normal functional connectivity dynamics in the participant (Fig. 4) . Although it still sounds surreal, efforts in the development of functional connectivity-based rtfMRI-nf are ongoing worldwide, and may one day represent a novel therapeutic option in clinical psychiatry.
CONCLUSIONS
Here, we have reviewed previous applications of computational neuroscience in psychiatry research and have thereby discussed its potential role in achieving a better understanding of the etiology and pathophysiology of mental disorders. While theorydriven approaches will provide an integrated view of the mental disorders by connecting the disorderspecific features derived at each level of the brain's organization, data-driven approaches may provide a common platform for making biology-based, quantitative diagnoses of, and treatments for, mental disorders. In fact, the application of machine-learning techniques to resting-state functional connectivity holds great promise as a means to enabling simultaneous diagnosis and treatment, thereby establishing 'theranostics' 170,171 for the first time in clinical neuropsychiatry in the near future. The values of disorder-specific functional connections (e.g., those incorporated into an functional-connectivity-based classifier) are calculated and are then (e) converted to a single number (score) indicating the participant's current proneness to a disorder before being (f) fed back to a participant who then attempts to self-regulate his/her activation level toward a preferred state.
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